Try Alerts Free   |   Login
Health Care › Services-Home Health Care Services

LHCG Price Correlated With Financials For LHC

Free historical financial statements for LHC Group Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 41 quarters since 2012. Compare with LHCG stock chart to see long term trends.

LHCG Stock Compared to Quarterly

LHCG Income Statement

Revenue, Net:571495000
Revenue Per Share:18.4181
Cost of Goods & Services Sold:350388000
Gross Profit:221107000
Selling, General & Admin Expense:184359000
Operating Income:35519000
Income Taxes:10944000
Net Income:24979000
Earnings Per Share, Basic:0.64
Shares Outstanding, Basic Avg:31029045

LHCG Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:5617000
Change in Accounts Receiveable:25538000
Net Cash from Operations:-64956000
Net Cash from Operations Per Share:-2.0934
Repurchases/Buybacks Common Stock:34565000
Net Cash from Financing Activities:69369000
Property, Plant & Equipment Purchases:6442000
Net Cash from Investing Activities:-6542000
Net Change in Cash & Equivalents:-2129000

LHCG Balance Sheet

Cash and Cash Equivalents:7680000
Accounts Receivable, Net:376968000
Total Current Assets:485240000
Property, Plant & Equipment, Net:156673000
Total Assets:2943540000
Total Short-Term Liabilities:343351000
Total Liabilities:1278194000
Organization LHC Group, Inc. (the “Company”) is a health care provider specializing in the post-acute continuum of care. The Company provides services through five segments: home health, hospice, home and community-based services, facility-based services, the latter primarily through long-term acute care hospitals ("LTACHs"), and healthcare innovations ("HCI").

As of December 31, 2021, the Company, through its wholly and majority-owned subsidiaries, equity joint ventures, controlled affiliates, and management agreements, operated 970 service providers in 37 states within the continental United States and the District of Columbia.

COVID-19 Update

SARS-CoV-2 ("COVID-19") continues to spread and various responses related to stay-at-home restrictions, travel restrictions, and other public health and safety measures continue to evolve. We communicate with our clinicians and other employees all updated policies and procedures as we monitor changes related to the pandemic. Policies and procedures related to social distancing and cleaning procedures remain in place as the safety of our patients and employees are vital. The effects of COVID-19 continue to materially impact our business. As a result, operating results for the twelve months ended December 31, 2021 may not be directly comparable to operating results for the twelve months ended December 31, 2020.


In response to COVID-19, the U.S. Government enacted the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") on March 27, 2020. The CARES Act was passed to provide $100 billion of Provider Relief Funds for distribution to eligible providers who provided diagnoses, testing, or care for individuals with a possible or actual case of COVID-19, specifically to reimburse providers for health care related expenses related to the prevention of the spread of COVID-19, preparations for treating cases of COVID-19 positive patients, and for lost revenues attributable to COVID-19. The CARES Act also provided financial hardship relief to Medicare providers impacted by the COVID-19 pandemic in order to provide necessary funds when there is a disruption in Medicare claims submission and/or Medicare claims processing by distributing funds through the Accelerated and Advanced Payments Program ("CAAP").

In addition, the CARES Act suspended the 2% sequestration payment adjustments on Medicare patient claims with dates of service from May 1 through December 31, 2020, suspended the application of site-neutral payment for LTACH admissions that were admitted during the Public Health Emergency ("PHE"), and delayed payment of the employer portion of social security tax. On April 14, 2021, Congress passed legislation to continue the suspension of the 2% sequestration payment adjustments on Medicare patient claims with dates of service through December 31, 2021. On December 10, 2021, the Protecting Medicare and American Farmers from Sequester Cuts Act legislation passed, which will continue the suspension of the sequestration payment adjustments for Medicare patient claims with dates of service through March 31, 2022. Medicare patient claims with dates of service between April 1 through June 30, 2022 will have 1% sequestration adjustment and Medicare patient claims with dates of service beginning July 1, 2022 will have 2% sequestration adjustment. On January 14, 2022, the U.S. Department of Health and Human Services extended the PHE until April 15, 2022.

Provider Relief Fund

During the twelve months ended December 31, 2020, the Company received $93.3 million in payments from the Provider Relief Fund, which was recorded as a short-term liability in government stimulus advance in our consolidated balance sheets. The Company returned all Provider Relief Funds received of $93.3 million to the government during the twelve months ended December 31, 2021.


During the twelve months ended December 31, 2020, the Company received $318.0 million of accelerated payments u

Data imported from LHC Group Inc. SEC filings. Check original filings before making any investment decision.